Review
doi: 10.1136/bmj.325.7360.381.
Systematic reviews and lifelong diseases
Affiliations
- PMID: 12183313
- PMCID: PMC1123891
- DOI: 10.1136/bmj.325.7360.381
Item in Clipboard
Review
Systematic reviews and lifelong diseases
BMJ.
.
No abstract available
Figures
Studies comparing β lactam antibiotic with β lactam and aminoglycoside combination. Outcome is number of patients with resistant strains of Pseudomonas aeruginosa
Similar articles
-
Single versus combination intravenous anti-pseudomonal antibiotic therapy for people with cystic fibrosis.Cochrane Database Syst Rev. 2021 Jun 23;6(6):CD002007. doi: 10.1002/14651858.CD002007.pub5. Cochrane Database Syst Rev. 2021. PMID: 34159577 Free PMC article.
-
Spaced administration of antibiotic combinations to eliminate pseudomonas from sputum in cystic fibrosis.Lancet. 1988 Sep 24;2(8613):749-50. doi: 10.1016/s0140-6736(88)90226-7. Lancet. 1988. PMID: 2901603 No abstract available.
-
Antibiotic choice for Pseudomonas pulmonary infections in children with cystic fibrosis.Pediatr Pulmonol Suppl. 1997;16:45. doi: 10.1002/ppul.1950230823. Pediatr Pulmonol Suppl. 1997. PMID: 9443192 Review. No abstract available.
-
Minimizing the toxicity of aminoglycosides in cystic fibrosis.J R Soc Med. 2010 Jul;103 Suppl 1(Suppl 1):S3-5. doi: 10.1258/jrsm.2010.s11002. J R Soc Med. 2010. PMID: 20573667 Free PMC article. No abstract available.
-
[How should chronic Pseudomonas aeruginosa bronchial infection be treated in the course of cystic fibrosis?].Rev Mal Respir. 2003 Apr;20(2 Pt 2):S129-35. Rev Mal Respir. 2003. PMID: 12910145 Review. French. No abstract available.
Cited by
-
Effectiveness of innovations in nurse led chronic disease management for patients with chronic obstructive pulmonary disease: systematic review of evidence.BMJ. 2005 Sep 3;331(7515):485. doi: 10.1136/bmj.38512.664167.8F. Epub 2005 Aug 10. BMJ. 2005. PMID: 16093253 Free PMC article.
-
Single versus combination intravenous anti-pseudomonal antibiotic therapy for people with cystic fibrosis.Cochrane Database Syst Rev. 2016 Dec 1;12(12):CD002007. doi: 10.1002/14651858.CD002007.pub4. Cochrane Database Syst Rev. 2016. Update in: Cochrane Database Syst Rev. 2021 Jun 23;6:CD002007. doi: 10.1002/14651858.CD002007.pub5. PMID: 27907224 Free PMC article. Updated.
-
Long term clinical outcome of home and hospital intravenous antibiotic treatment in adults with cystic fibrosis.Thorax. 2004 Mar;59(3):242-6. doi: 10.1136/thx.2003.005876. Thorax. 2004. PMID: 14985563 Free PMC article.
-
Pharmacotherapy for weight loss in adults with type 2 diabetes mellitus.Cochrane Database Syst Rev. 2005 Jan 25;2005(1):CD004096. doi: 10.1002/14651858.CD004096.pub2. Cochrane Database Syst Rev. 2005. PMID: 15674929 Free PMC article.
-
Single versus combination intravenous anti-pseudomonal antibiotic therapy for people with cystic fibrosis.Cochrane Database Syst Rev. 2021 Jun 23;6(6):CD002007. doi: 10.1002/14651858.CD002007.pub5. Cochrane Database Syst Rev. 2021. PMID: 34159577 Free PMC article.
References
-
- Li wan Po A, Herxheimer A, Poolsup N, Aziz Z. 8th Cochrane Colloquium abstract. Cape Town, South Africa. 2001. How do Cochrane reviewers address adverse effects of drug therapy?
-
- Elphick HE, Tan A. Cochrane Library. Issue 3. Oxford: Update Software; 2001. Single versus combination intravenous antibiotic therapy for people with cystic fibrosis. - PubMed
-
- Schulz K, Chalmers I, Hayes R, Altman DG. Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effect in controlled clinical trials. JAMA. 1995;273:408–412. - PubMed
-
- Smith A, Doershuk C, Goldmann D, Gore E, Hilman B, Marks M, et al. Comparison of a beta-lactam alone versus beta-lactam and an aminoglycoside for pulmonary exacerbation in cystic fibrosis. J Pediatr. 1999;134:413–421. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
